SCHEMBL777768

SCHEMBL777768

O=S(=O)(c1c(F)c(F)c(F)c(F)c1F)c1c(F)c(F)c(F)c(F)c1F

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 15/20 0.56
CA2 P00918 15/20 0.56
CA12 O43570 5/20 0.56
CA7 P43166 5/20 0.56
CA13 Q8N1Q1 5/20 0.56
F2 P00734 3/20 0.48
PRSS1 P07477 3/20 0.48
PRSS2 P07478 3/20 0.48
PRSS3 P35030 3/20 0.48
MMP1 P03956 1/20 0.48
MMP2 P08253 1/20 0.48
MMP9 P14780 1/20 0.48
MMP8 P22894 1/20 0.48
MMP13 P45452 1/20 0.48
CA9 Q16790 2/20 0.35
CA3 P07451 1/20 0.32
CA4 P22748 1/20 0.32
CA6 P23280 1/20 0.32
CA5A P35218 1/20 0.32
CA14 Q9ULX7 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7871429 0.83 CA1 (0.48) CA1CA2CA12CA7CA13
SCHEMBL8011470 0.83 CA1 (0.48) CA1CA2CA12CA7CA13
SCHEMBL2477379 0.81 CA1 (0.53) CA1CA2CA12CA7CA13
SCHEMBL12629275 0.81 CA1 (0.39) CA1CA2CA12CA7CA13
SCHEMBL7868522 0.81 CA1 (0.46) CA1CA2CA12CA7CA13
SCHEMBL14062567 0.81 F2 (0.41) CA1CA2CA12CA7CA13
SCHEMBL24758489 0.79 CA1 (0.44) CA1CA2CA12CA7CA13
SCHEMBL12360278 0.79 CA1 (0.39) CA1CA2CA12CA7CA13
SCHEMBL24758487 0.79 CA1 (0.39) CA1CA2CA12CA7CA13
SCHEMBL12360293 0.79 CA1 (0.39) CA1CA2CA12CA7CA13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 125 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113637167-B Branched polyaromatic ether and preparation method thereof 天津师范大学 2024-03-01 CN claimed
US-10087128-B2 Fluorinated aromatic compound, method for its production, curable material, its cured product, and optical member AGC Inc. (JP) 2018-10-02 US claimed
EP-3031793-B1 FLUORINATED AROMATIC COMPOUND, METHOD FOR ITS PRODUCTION, CURABLE MATERIAL, ITS CURED PRODUCT, AND OPTICAL MEMBER ASAHI GLASS CO LTD (JP) 2018-03-21 EP claimed
EP-3031793-A1 FLUORINE-CONTAINING AROMATIC COMPOUND, METHOD FOR PRODUCING SAME, CURABLE MATERIAL, CURED PRODUCT THEREOF, AND OPTICAL MEMBER Asahi Glass Company, Limited (JP) 2016-06-15 EP claimed
US-20160137572-A1 FLUORINATED AROMATIC COMPOUND, METHOD FOR ITS PRODUCTION, CURABLE MATERIAL, ITS CURED PRODUCT, AND OPTICAL MEMBER ASAHI GLASS COMPANY, LIMITED (JP) 2016-05-19 US claimed
US-20110065021-A1 Novel Sulfonic-Acid-Group-Containing Segmented Block Copolymer, Application Thereof, and Method of Manufacturing Novel Block Copolymer TOYO BOSEKI KABUSHIKI KAISHA (JP) 2011-03-17 US claimed
EP-2289973-A1 NOVEL SULFONIC ACID GROUP-CONTAINING SEGMENTALIZED BLOCK COPOLYMER, USE THEREOF, AND METHOD FOR PRODUCING NOVEL BLOCK COPOLYMER Toyo Boseki Kabushiki Kaisha (JP) 2011-03-02 EP claimed
US-20090221787-A1 Production Of Monomer, Oligomer And Polymer Phosphonic Acid Esters And Phosphonic And Sulphonic Acids By A Nucleophile Aromatic Substitution HARING THOMAS 2009-09-03 US claimed
EP-1931608-A1 PRODUCTION OF MONOMER, OLIGOMER AND POLYMER PHOSPHONIC ACID ESTERS AND PHOSPHONIC AND SULPHONIC ACIDS BY A NUCLEOPHILE AROMATIC SUBSTITUTION Universität Stuttgart (DE) 2008-06-18 EP claimed
WO-2007006300-A1 PRODUCTION OF MONOMER, OLIGOMER AND POLYMER PHOSPHONIC ACID ESTERS AND PHOSPHONIC AND SULPHONIC ACIDS BY A NUCLEOPHILE AROMATIC SUBSTITUTION Universität Stuttgart (DE) 2007-01-18 WO claimed
WO-2006066569-A2 IONOMERS AND IONOMER BLENDS BASED ON PARTIALLY FLUORINATED POLY(HETERO)ARYLS HÄRING, Thomas (DE) 2006-06-29 WO claimed
US-20250161498-A1 COMPOSITIONS AND METHODS OF DETECTING AND TREATING THROMBOSIS AND VASCULAR PLAQUES Microvascular Therapeutics LLC (US) 2025-05-22 US disclosed
US-12100809-B2 Non-aqueous liquid electrolyte and non-aqueous liquid electrolyte secondary battery MITSUBISHI CHEMICAL CORPORATION (JP) 2024-09-24 US disclosed
US-20240302387-A1 HIGHLY FLUORINATED COMPOUNDS FOR 19F MRI-BASED THERMOMETRY REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2024-09-12 US disclosed
US-20240148914-A1 COMPOSITIONS AND METHODS OF DETECTING AND TREATING THROMBOSIS AND VASCULAR PLAQUES Microvascular Therapeutics LLC (US) 2024-05-09 US disclosed
US-6028159-A Polyamideimide for optical communications and method for preparing the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2000-02-22 US disclosed
US-6013759-A Polyamideimide for optical communications and method for preparing the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2000-01-11 US disclosed
CN-1226571-A Polyamideimide for optical communications and method for preparing the same SAMSUNG ELECTRONICS CO LTD (KR) 1999-08-25 CN disclosed
CN-1224030-A Polyamideimide for optical communications and method for preparing the same SAMSUNG ELECTRONICS CO LTD (KR) 1999-07-28 CN disclosed
CN-1212973-A Polyimide for optical communications and method for preparing the same SAMSUNG ELECTRONICS CO LTD (KR) 1999-04-07 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250161498-A1 COMPOSITIONS AND METHODS OF DETECTING AND TREATING THROMBOSIS AND VASCULAR PLAQUES FGB, APOB, PSMB5 CA1 3508/4885CA2 4570/4885CA12 3260/4885
US-20160137572-A1 FLUORINATED AROMATIC COMPOUND, METHOD FOR ITS PRODUCTION, CURABLE MATERIAL, ITS CURED PRODUCT, AND OPTICAL MEMBER AFF1, AFF2, AFF4 CA1 716/4885CA2 824/4885CA12 946/4885
US-10087128-B2 Fluorinated aromatic compound, method for its production, curable material, its cured product, and optical member AFF1, AFF2, AFF4 CA1 716/4885CA2 824/4885CA12 946/4885
US-20090221787-A1 Production Of Monomer, Oligomer And Polymer Phosphonic Acid Esters And Phosphonic And Sulphonic Acids By A Nucleophile Aromatic Substitution PFKFB2, PFKFB4, PFKFB1 CA1 1698/4885CA2 546/4885CA12 1248/4885
US-20240302387-A1 HIGHLY FLUORINATED COMPOUNDS FOR 19F MRI-BASED THERMOMETRY SLC19A1, UGT2B17, GDI1 CA1 167/4885CA2 1195/4885CA12 178/4885
US-20240148914-A1 COMPOSITIONS AND METHODS OF DETECTING AND TREATING THROMBOSIS AND VASCULAR PLAQUES FGB, APOB, FLT4 CA1 4051/4885CA2 4638/4885CA12 2771/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.